{"url":"https://lda.senate.gov/api/v1/filings/174a3839-c3fd-4eec-a769-ad6a2f42e00e/","filing_uuid":"174a3839-c3fd-4eec-a769-ad6a2f42e00e","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2025,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/174a3839-c3fd-4eec-a769-ad6a2f42e00e/print/","filing_document_content_type":"text/html","income":"20000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Michael Shupp, Vice President","dt_posted":"2025-07-21T07:47:30-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"800 Maine Avenue, SW","registrant_address_2":"Suite 800","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20024","registrant":{"id":39837,"url":"https://lda.senate.gov/api/v1/registrants/39837/","house_registrant_id":32802,"name":"VAN SCOYOC ASSOCIATES","description":"Government Relations Consultant","address_1":"800 Maine Avenue, SW","address_2":"Suite 800","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20024","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"H. STEWART VAN SCOYOC","contact_telephone":"+1 202-638-1950","dt_updated":"2026-07-30T13:26:38.045563-04:00"},"client":{"id":53483,"url":"https://lda.senate.gov/api/v1/clients/53483/","client_id":53483,"name":"MEMSEL, INC.","general_description":"Scientific research & development company","client_government_entity":null,"client_self_select":false,"state":"TX","state_display":"Texas","country":"US","country_display":"United States of America","ppb_state":"TX","ppb_state_display":"Texas","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2022-11-01"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act,FY2024 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48722,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ANTHONY","last_name":"SHUPP","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":47487,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"CAVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148451,"prefix":null,"prefix_display":null,"first_name":"MADHUMITHA","nickname":null,"middle_name":null,"last_name":"THYAGARAJAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act,FY2024 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48722,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ANTHONY","last_name":"SHUPP","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":47487,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"CAVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148451,"prefix":null,"prefix_display":null,"first_name":"MADHUMITHA","nickname":null,"middle_name":null,"last_name":"THYAGARAJAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Development of Advanced Wound Healing System; Advanced Wound Healing System and Phage Therapeutics, as follows: Public Law 118-47, Further Consolidated Appropriations Act, 2024, Division A - Department of Defense Appropriations Act,FY2024 H.R.8774/S.4921, Department of Defense Appropriations Act, FY2025 H.R.4016, Department of Defense Appropriations Act, FY2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":48722,"prefix":"mr","prefix_display":"MR.","first_name":"MICHAEL","nickname":null,"middle_name":"ANTHONY","last_name":"SHUPP","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":47487,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"CAVE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":148451,"prefix":null,"prefix_display":null,"first_name":"MADHUMITHA","nickname":null,"middle_name":null,"last_name":"THYAGARAJAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}